In contrast, protein levels of FPN in the liver, tested by WB, were significantly higher in SCD mice than in control mice, suggesting reduced levels of plasma HAMP in SCD (Figure 3H,I, FPN/β-actin 1.09 ± 0.08 in SCD vs. 0.49 ± 0.07 in control, p = 0016). This evidence concerns the gene ACTB and Schnyder corneal dystrophy.